ZURA BIO LTD (ZURA) Stock Overview
USA - NASDAQ:ZURA - KYG9TY5A1016 - Common Stock
ZURA Key Statistics, Chart & Performance
The current stock price of ZURA is 3.4 USD. In the past month the price increased by 65.05%. In the past year, price decreased by -28.27%.
ZURA Latest News, Press Relases and Analysis
ZURA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.85 | 408.76B | ||
| AMGN | AMGEN INC | 13.81 | 162.12B | ||
| GILD | GILEAD SCIENCES INC | 16.03 | 153.96B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.16 | 109.29B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 62.13B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.69 | 61.40B | ||
| ARGX | ARGENX SE - ADR | 90.64 | 51.39B | ||
| INSM | INSMED INC | N/A | 34.94B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.1 | 34.68B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.70B | ||
| NTRA | NATERA INC | N/A | 25.65B | ||
| BIIB | BIOGEN INC | 9.13 | 21.44B |
Related stock screener links
About ZURA
Company Profile
Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. The company is headquartered in La Jolla, California and currently employs 30 full-time employees. The company went IPO on 2021-07-16. The company is developing three assets which have completed Phase I/Ib studies. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880) with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases, including systemic sclerosis and other indications with unmet needs. ZB-106 is an immunoglobulin G single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of TALTZ and tabalumab that neutralize interleukin-17A (IL-17A) and BAFF. ZB-168 is a fully human, high affinity monoclonal antibody that binds and neutralizes the IL-7 receptor chain alpha chain. ZB-880 is a fully human, high affinity monoclonal antibody that neutralizes IL-33, preventing ST2-dependent and ST2-independent inflammation.
Company Info
ZURA BIO LTD
4225 Executive Square, Suite 600
La Jolla CALIFORNIA US
Employees: 30
Phone: 18582470520
ZURA BIO LTD / ZURA FAQ
What is the stock price of ZURA BIO LTD today?
The current stock price of ZURA is 3.4 USD. The price increased by 0.89% in the last trading session.
What is the ticker symbol for ZURA BIO LTD stock?
The exchange symbol of ZURA BIO LTD is ZURA and it is listed on the Nasdaq exchange.
On which exchange is ZURA stock listed?
ZURA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ZURA BIO LTD stock?
13 analysts have analysed ZURA and the average price target is 13.6 USD. This implies a price increase of 300% is expected in the next year compared to the current price of 3.4. Check the ZURA BIO LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ZURA BIO LTD worth?
ZURA BIO LTD (ZURA) has a market capitalization of 221.07M USD. This makes ZURA a Micro Cap stock.
How many employees does ZURA BIO LTD have?
ZURA BIO LTD (ZURA) currently has 30 employees.
What are the support and resistance levels for ZURA BIO LTD (ZURA) stock?
ZURA BIO LTD (ZURA) has a support level at 3.2. Check the full technical report for a detailed analysis of ZURA support and resistance levels.
Should I buy ZURA BIO LTD (ZURA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ZURA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ZURA, evaluating the profitability, health, valuation and growth aspects
- ZURA BIO LTD (ZURA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ZURA BIO LTD (ZURA) Sales and EPS estimates to see what analysts future expectations are.
- ZURA BIO LTD (ZURA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ZURA BIO LTD (ZURA) Insider and Institutional Ownership to learn about the owners and their transactions.
- ZURA BIO LTD (ZURA) Stock Chart to make your own analysis
- ZURA BIO LTD (ZURA) Latest news and press-releases to stay up to date.
Does ZURA BIO LTD (ZURA) stock pay dividends?
ZURA does not pay a dividend.
When does ZURA BIO LTD (ZURA) report earnings?
ZURA BIO LTD (ZURA) will report earnings on 2025-11-05, before the market open.
What is the Price/Earnings (PE) ratio of ZURA BIO LTD (ZURA)?
ZURA BIO LTD (ZURA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.72).
What is the Short Interest ratio of ZURA BIO LTD (ZURA) stock?
The outstanding short interest for ZURA BIO LTD (ZURA) is 0.98% of its float. Check the ownership tab for more information on the ZURA short interest.
ZURA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ZURA. When comparing the yearly performance of all stocks, ZURA is one of the better performing stocks in the market, outperforming 90.17% of all stocks.
ZURA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ZURA. ZURA has a great financial health rating, but its profitability evaluates not so good.
ZURA Financial Highlights
Over the last trailing twelve months ZURA reported a non-GAAP Earnings per Share(EPS) of -0.72. The EPS decreased by -28.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -41.46% | ||
| ROE | -51.96% | ||
| Debt/Equity | 0 |
ZURA Forecast & Estimates
13 analysts have analysed ZURA and the average price target is 13.6 USD. This implies a price increase of 300% is expected in the next year compared to the current price of 3.4.